Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

885.2500 1.50 (0.17%)

NSE Jul 04, 2025 15:31 PM

47.15% Fall from 52W High

Volume: 352.3K

Strides Pharma Science Ltd.

06 Sep 2024, 10:04AM

885.25

0.17%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300mg and 450mg

More from Strides Pharma Science Ltd.

Recommended

Five Interesting Stocks Today - July 04, 2025

The Baseline | 04 Jul 2025

Market closes higher, Bajaj Finance's AUM grows 25% YoY crore in Q1FY26

Trendlyne Marketwatch | 04 Jul 2025

Earnings Call Transcript - Q1FY21 for Strides Pharma Science

| 05 Aug 2020, 05:36PM